A truly disruptive diagnostic platform which has the potential to revolutionize the detection, diagnosis and management of a concussion

BioDirection, a privately held medical device company developing novel and rapid point-of-care products for the objective detection of concussion and other traumatic brain injury (TBI), today announced that it recently filed a Pre-Submission (“Pre-Sub”) Package with the FDA as a critical step toward commercialization of its proprietary Tbit™ diagnostic platform. BioDirection’s Pre-Sub meeting with FDA Read more about A truly disruptive diagnostic platform which has the potential to revolutionize the detection, diagnosis and management of a concussion[…]

Haptic
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.